BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38041107)

  • 21. MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2.
    Zhu H; Hou L; Liu J; Li Z
    Biochem Biophys Res Commun; 2016 Feb; 471(1):169-76. PubMed ID: 26826389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory role for Krüppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis.
    Nakanishi G; Kim YS; Nakajima T; Jetten AM
    J Invest Dermatol; 2006 Jan; 126(1):49-60. PubMed ID: 16417217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF.
    Man XY; Yang XH; Cai SQ; Bu ZY; Zheng M
    J Cell Mol Med; 2008 Apr; 12(2):649-60. PubMed ID: 18419602
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Zhang H; Ren C; Liu Q; Wang Q; Wang D
    Allergol Immunopathol (Madr); 2023; 51(3):124-134. PubMed ID: 37169570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
    Honma M; Minami-Hori M; Takahashi H; Iizuka H
    J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS.
    Szegedi K; Sonkoly E; Nagy N; Németh IB; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
    Exp Dermatol; 2010 Mar; 19(3):269-78. PubMed ID: 20377629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
    Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
    J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin/integrin α9 signaling.
    Chowdhari S; Sardana K; Saini N
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3142-3152. PubMed ID: 28844950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
    Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
    J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.
    Werner S; Beer HD; Mauch C; Lüscher B; Werner S
    Oncogene; 2001 Nov; 20(51):7494-504. PubMed ID: 11709721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing.
    Sobolev VV; Mezentsev AV; Ziganshin RH; Soboleva AG; Denieva M; Korsunskaya IM; Svitich OA
    PLoS One; 2021; 16(5):e0240956. PubMed ID: 34038424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
    Johansen C; Funding AT; Otkjaer K; Kragballe K; Jensen UB; Madsen M; Binderup L; Skak-Nielsen T; Fjording MS; Iversen L
    J Immunol; 2006 Feb; 176(3):1431-8. PubMed ID: 16424170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis-Associated Inflammatory Conditions Induce IL-23 mRNA Expression in Normal Human Epidermal Keratinocytes.
    Kelemen E; Ádám É; Sági SM; Göblös A; Kemény L; Bata-Csörgő Z; Széll M; Danis J
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
    Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
    J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
    Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
    Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?
    Rückert R; Asadullah K; Seifert M; Budagian VM; Arnold R; Trombotto C; Paus R; Bulfone-Paus S
    J Immunol; 2000 Aug; 165(4):2240-50. PubMed ID: 10925312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
    Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
    Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
    Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
    Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin.
    Staiano-Coico L; Gottlieb AB; Barazani L; Carter DM
    J Invest Dermatol; 1987 May; 88(5):646-51. PubMed ID: 2437219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.